Skip to content

Company information lookup

BIONOMICS LIMITED (BNO)

Developer of innovative treatments for cancer and diseases of the central nervous system.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BNO 0.490 1.03% 0.480 0.495 0.500 0.510 0.490 86,300

BIONOMICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BNO
Securities
Official Listing Date 21 December, 1999
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.bionomics.com.au
Registered Office Address 31 Dalgleish Street, THEBARTON, SA, AUSTRALIA, 5031
Head Office Telephone 08 8354 6100
Head Office Fax 08 8354 6199
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 5, 115 GRENFELL STREET, ADELAIDE, SA, AUSTRALIA, 5000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Graeme Kaufman (Chairman)
Dr Deborah Rathjen (Managing Director, CEO)
Dr Errol De Souza (Non Exec. Director)
Dr Jonathan Lim (Non Exec. Director)
Mr Trevor Tappenden (Non Exec. Director)
Ms Melanie Young (CFO)
Company Secretary Ms Melanie Young
Principal Activities Developer of innovative treatments for cancer and diseases of the central nervous system.

BIONOMICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
20/11/2014   Amended Change of Director's Interest Notice 3 PDF
20/11/2014   BNC101 Data Presented at European Cancer Conference 2 PDF
18/11/2014   Change of Director's Interest Notice 2 PDF
18/11/2014   Appendix 3B 12 PDF
18/11/2014   Change of Director's Interest Notice 2 PDF
17/11/2014   BNC210 Data To Be Presented At US Conference 2 PDF
12/11/2014   Annual General Meeting 2014 Results 2 PDF
12/11/2014   CEO & Managing Director's AGM Presentation 2014 27 PDF
11/11/2014 asterix Bionomics To Progress BNC210 In Clinical Trials 3 PDF
31/10/2014 asterix Appendix 4C - quarterly 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Nov 2014 0.490 1.03% 0.510 0.490 86,300
20 Nov 2014 0.485 -5.83% 0.515 0.485 79,704
19 Nov 2014 0.515 -4.63% 0.535 0.510 75,884
18 Nov 2014 0.540 -0.92% 0.540 0.535 113,496
17 Nov 2014 0.545 -1.8% 0.545 0.530 84,794

* Volume of shares shown represents only those shares traded on ASX.

BIONOMICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BNO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BNO

Warrants & Structured Products

No warrants & Structured Products are available over the security BNO